Pharmacoepidemiology and drug safetyHumansHypothyroidismFemaleMaleMiddle Aged
The Risk of Hypothyroidism With the Use of GLP-1 Receptor Agonists in Saudi Arabia.
Almaha Alfakhri, Ohoud Almadani, Raseel Alroba, Adel Alrwisan, Omar Alshaya, Yasser Albogami
Published: 202610.1002/pds.70315
Abstract
AIM: Preclinical studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may induce thyroid gland hyperplasia, raising concerns about potential thyroid-related risks. Given their increasing use and the limited evidence on thy…
Preview only. Read the full abstract at the source